165 related articles for article (PubMed ID: 38027108)
1. Biological and clinical significance of radiomics features obtained from magnetic resonance imaging preceding pre-carbon ion radiotherapy in prostate cancer based on radiometabolomics.
Zhang G; Zhang Z; Pei Y; Hu W; Xue Y; Ning R; Guo X; Sun Y; Zhang Q
Front Endocrinol (Lausanne); 2023; 14():1272806. PubMed ID: 38027108
[TBL] [Abstract][Full Text] [Related]
2. Imaging-Based Individualized Response Prediction Of Carbon Ion Radiotherapy For Prostate Cancer Patients.
Wu S; Jiao Y; Zhang Y; Ren X; Li P; Yu Q; Zhang Q; Wang Q; Fu S
Cancer Manag Res; 2019; 11():9121-9131. PubMed ID: 31695500
[TBL] [Abstract][Full Text] [Related]
3. MRI-Derived Radiomics Model to Predict the Biochemical Recurrence of Prostate Cancer Following Seed Brachytherapy.
Zhu X; Liu Z; He J; Li Z; Huang Y; Lu J
Arch Esp Urol; 2023 Jun; 76(4):264-269. PubMed ID: 37455525
[TBL] [Abstract][Full Text] [Related]
4. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
[TBL] [Abstract][Full Text] [Related]
5. Role of radiomic analysis of [
Marturano F; Guglielmo P; Bettinelli A; Zattoni F; Novara G; Zorz A; Sepulcri M; Gregianin M; Paiusco M; Evangelista L
Eur Radiol; 2023 Oct; 33(10):7199-7208. PubMed ID: 37079030
[TBL] [Abstract][Full Text] [Related]
6. Carbon Ion Radiotherapy Evokes a Metabolic Reprogramming and Individualized Response in Prostate Cancer.
Ning R; Pei Y; Li P; Hu W; Deng Y; Hong Z; Sun Y; Zhang Q; Guo X
Front Public Health; 2021; 9():777160. PubMed ID: 34950631
[No Abstract] [Full Text] [Related]
7. MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218).
Gugliandolo SG; Pepa M; Isaksson LJ; Marvaso G; Raimondi S; Botta F; Gandini S; Ciardo D; Volpe S; Riva G; Rojas DP; Zerini D; Pricolo P; Alessi S; Petralia G; Summers PE; Mistretta FA; Luzzago S; Cattani F; De Cobelli O; Cassano E; Cremonesi M; Bellomi M; Orecchia R; Jereczek-Fossa BA
Eur Radiol; 2021 Feb; 31(2):716-728. PubMed ID: 32852590
[TBL] [Abstract][Full Text] [Related]
8. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
[TBL] [Abstract][Full Text] [Related]
9. Rectal wall MRI radiomics in prostate cancer patients: prediction of and correlation with early rectal toxicity.
Abdollahi H; Mahdavi SR; Mofid B; Bakhshandeh M; Razzaghdoust A; Saadipoor A; Tanha K
Int J Radiat Biol; 2018 Sep; 94(9):829-837. PubMed ID: 29969358
[TBL] [Abstract][Full Text] [Related]
10. The metabolic repression effect of carbon-ion radiotherapy in synchronous hormone-sensitive oligometastatic prostate cancer.
Zhang Z; Pei Y; Hu W; Xue Y; Ning R; Guo X; Sun Y; Zhang Q
Front Endocrinol (Lausanne); 2023; 14():1291653. PubMed ID: 38027094
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging radiomic feature analysis of radiation-induced femoral head changes in prostate cancer radiotherapy.
Abdollahi H; Mahdavi SR; Shiri I; Mofid B; Bakhshandeh M; Rahmani K
J Cancer Res Ther; 2019 Mar; 15(Supplement):S11-S19. PubMed ID: 30900614
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
13. Radiomic-based machine learning model for the accurate prediction of prostate cancer risk stratification.
Shu X; Liu Y; Qiao X; Ai G; Liu L; Liao J; Deng Z; He X
Br J Radiol; 2023 Mar; 96(1143):20220238. PubMed ID: 36475858
[TBL] [Abstract][Full Text] [Related]
14. MRI response of obturator internus muscle to carbon-ion dose in prostate cancer treatment.
Kawahara M; Kawamura H; Kubota Y; Katoh H; Kubo N; Shimada H; Torikai K; Torikoshi M; Kanai T; Nakano T
J Radiat Res; 2019 May; 60(3):335-341. PubMed ID: 30668869
[TBL] [Abstract][Full Text] [Related]
15. MRI Radiomic Analysis of IMRT-Induced Bladder Wall Changes in Prostate Cancer Patients: A Relationship with Radiation Dose and Toxicity.
Abdollahi H; Tanha K; Mofid B; Razzaghdoust A; Saadipoor A; Khalafi L; Bakhshandeh M; Mahdavi SR
J Med Imaging Radiat Sci; 2019 Jun; 50(2):252-260. PubMed ID: 31176433
[TBL] [Abstract][Full Text] [Related]
16. Predicting Model of Biochemical Recurrence of Prostate Carcinoma (PCa-BCR) Using MR Perfusion-Weighted Imaging-Based Radiomics.
An P; Lin Y; Hu Y; Qin P; Ye Y; Gu W; Li X; Song P; Feng G
Technol Cancer Res Treat; 2023; 22():15330338231166766. PubMed ID: 37016971
[TBL] [Abstract][Full Text] [Related]
17. Robustness of magnetic resonance imaging and positron emission tomography radiomic features in prostate cancer: Impact on recurrence prediction after radiation therapy.
Dutta A; Chan J; Haworth A; Dubowitz DJ; Kneebone A; Reynolds HM
Phys Imaging Radiat Oncol; 2024 Jan; 29():100530. PubMed ID: 38275002
[TBL] [Abstract][Full Text] [Related]
18. Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study.
Hu L; Zhou DW; Fu CX; Benkert T; Jiang CY; Li RT; Wei LM; Zhao JG
Eur Radiol; 2021 Mar; 31(3):1760-1769. PubMed ID: 32935192
[TBL] [Abstract][Full Text] [Related]
19. Carbon ion radiotherapy for prostate cancer with bladder invasion.
Miyasaka Y; Kawamura H; Sato H; Kubo N; Mizukami T; Matsui H; Miyazawa Y; Ito K; Nakano T; Suzuki K; Ohno T
BMC Urol; 2021 Aug; 21(1):106. PubMed ID: 34362355
[TBL] [Abstract][Full Text] [Related]
20. Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy.
Spohn SKB; Schmidt-Hegemann NS; Ruf J; Mix M; Benndorf M; Bamberg F; Makowski MR; Kirste S; Rühle A; Nouvel J; Sprave T; Vogel MME; Galitsnaya P; Gschwend JE; Gratzke C; Stief C; Löck S; Zwanenburg A; Trapp C; Bernhardt D; Nekolla SG; Li M; Belka C; Combs SE; Eiber M; Unterrainer L; Unterrainer M; Bartenstein P; Grosu AL; Zamboglou C; Peeken JC
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2537-2547. PubMed ID: 36929180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
